In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Terns Pharmaceuticals Inc’s stock clocked out at $40.11, down -0.72% from its previous closing price of $40.4. In other words, the price has decreased by -$0.72 from its previous closing price. On the day, 1.78 million shares were traded. TERN stock price reached its highest trading level at $41.263 during the session, while it also had its lowest trading level at $38.78.
Ratios:
To gain a deeper understanding of TERN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.52 and its Current Ratio is at 19.52. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 15, 2025, Truist started tracking the stock assigning a Buy rating and target price of $20.Truist initiated its Buy rating on October 15, 2025, with a $20 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 04 ’25 when Quigley Jill M. sold 24,520 shares for $18.00 per share. The transaction valued at 441,360 led to the insider holds 0 shares of the business.
JILL QUIGLEY bought 24,520 shares of TERN for $344,016 on Nov 04 ’25. On Oct 01 ’25, another insider, Kuriakose Emil, who serves as the Chief Medical Officer of the company, sold 944 shares for $7.85 each. As a result, the insider received 7,407 and left with 51,520 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TERN now has a Market Capitalization of 4362655744 and an Enterprise Value of 3318493952.
Stock Price History:
The Beta on a monthly basis for TERN is -0.28, which has changed by 6.0245185 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, TERN has reached a high of $48.26, while it has fallen to a 52-week low of $1.87. The 50-Day Moving Average of the stock is 43.75%, while the 200-Day Moving Average is calculated to be 273.16%.
Shares Statistics:
It appears that TERN traded 3.85M shares on average per day over the past three months and 2404400 shares per day over the past ten days. A total of 106.33M shares are outstanding, with a floating share count of 89.96M. Insiders hold about 15.40% of the company’s shares, while institutions hold 69.20% stake in the company. Shares short for TERN as of 1765756800 were 12767752 with a Short Ratio of 3.31, compared to 1763078400 on 9515874. Therefore, it implies a Short% of Shares Outstanding of 12767752 and a Short% of Float of 11.74.
Earnings Estimates
The dynamic stock of Terns Pharmaceuticals Inc (TERN) is currently being evaluated by a team of 10.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.25 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$1.01 and -$1.2 for the fiscal current year, implying an average EPS of -$1.09. EPS for the following year is -$1.22, with 10.0 analysts recommending between -$0.76 and -$1.54.
